William B. Walkup & Associates’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Sell
9,646
-6
-0.1% -$1.58K 1.3% 21
2026
Q1
$2.25M Buy
9,652
+6
+0.1% +$1.63K 1.34% 20
2025
Q4
$2.42M Sell
9,646
-6
-0.1% -$1.59K 1.32% 22
2025
Q3
$2.77M Hold
9,652
1.48% 17
2025
Q2
$2.53M Hold
9,652
1.49% 17
2025
Q1
$2.25M Buy
9,652
+166
+2% +$40.3K 1.37% 19
2024
Q4
$2.18M Hold
9,486
1.38% 21
2024
Q3
$2.12M Buy
+9,486
New +$2.08M 1.31% 21

Other funds holding LH

William B. Walkup & Associates's LH Position: Q2 2026 in Review

William B. Walkup & Associates reduced its Labcorp (LH) stake by 0.06% in Q2 2026, selling an estimated $1.58K and leaving 9,646 shares worth $2.7M. The position accounts for 1.3% of the portfolio, ranked #21.

William B. Walkup & Associates first reported a position in LH in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.77M in Q3 2025. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • William B. Walkup & Associates held 9,646 shares of Labcorp worth $2.7M as of Q2 2026.
  • William B. Walkup & Associates sold 6 Labcorp shares in Q2 2026, an estimated $1.58K.
  • Labcorp made up 1.3% of William B. Walkup & Associates's portfolio in Q2 2026, its #21 holding.
  • William B. Walkup & Associates first reported a position in Labcorp in Q3 2024 and has held it in 8 quarters since.
  • William B. Walkup & Associates's Labcorp position peaked at $2.77M in Q3 2025.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.